Cargando…
The use of solvent-preserved human and bovine cancellous bone blocks for lateral defect augmentation - an experimental controlled study in vivo
BACKGROUND: The aim of this study was to compare new bone formation, resorbed bone matrix, and fibrous enclosed residual bone substitute material in laterally augmented alveolar bone defects using allogeneic, pre-treated and cleaned human bone blocks (tested in dogs, therefore considered to be xenog...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240406/ https://www.ncbi.nlm.nih.gov/pubmed/34187496 http://dx.doi.org/10.1186/s13005-021-00275-1 |
_version_ | 1783715210889003008 |
---|---|
author | Schorn, Lara Fienitz, Tim Berndsen, Kathrin Kübler, Norbert R. Holtmann, Henrik Rothamel, Daniel |
author_facet | Schorn, Lara Fienitz, Tim Berndsen, Kathrin Kübler, Norbert R. Holtmann, Henrik Rothamel, Daniel |
author_sort | Schorn, Lara |
collection | PubMed |
description | BACKGROUND: The aim of this study was to compare new bone formation, resorbed bone matrix, and fibrous enclosed residual bone substitute material in laterally augmented alveolar bone defects using allogeneic, pre-treated and cleaned human bone blocks (tested in dogs, therefore considered to be xenogeneic), and pre-treated and cleaned bovine cancellous bone blocks, both with and without a collagen membrane in order to evaluate their augmentative potential. METHODS: Thirty-two critical size horizontal defects were prepared in the mandible of 4 adult foxhound dogs (8 per dog, 4 on each side). After 3 months of healing, the defects were laterally augmented in a split-mouth-design with either human (HXB) or bovine solvent-preserved bone blocks (BXB). Afterwards, defects were randomly covered with a bovine collagenous membrane (HXB + M, BXB + M). After a healing interval of 6 months, percentages of new bone formation, resorbed bone matrix, and fibrous enclosed residual bone substitute material were compared. RESULTS: Results showed little new bone formation of up to 3.7 % in human bone blocks (HXB 3.7 % ± 10.2, HXB + M 0.3 %± 0.4, BXB, 0.1 % ± 0.8, BXB + M 2.6 % ± 3.2, p = > 0.05). Percentages of fibrous encapsulation were higher in human bone blocks than in bovine bone blocks (HXB 71.2 % ± 8.6, HXB + M 73.71 % ± 10.6, BXB, 60.5 % ± 27.4, BXB + M 52.5 % ± 28.4, p = > 0.05). Resorption rates differed from 44.8 % in bovine bone blocks covered with a membrane to 17.4 % in human bone blocks (HXB 17.4 % ± 7.4, HXB + M 25.9 % ± 10.7, BXB, 38.4 % ± 27.2, BXB + M 44.8 % ± 29.6, p = > 0.05). The use of additional membranes did not significantly affect results. CONCLUSIONS: Within its limitations, results of this study suggest that solvent-preserved xenogenic human and bovine bone blocks are not suitable for lateral bone augmentation in dogs. Furthermore, defect coverage with a membrane does not positively affect the outcome. |
format | Online Article Text |
id | pubmed-8240406 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-82404062021-06-30 The use of solvent-preserved human and bovine cancellous bone blocks for lateral defect augmentation - an experimental controlled study in vivo Schorn, Lara Fienitz, Tim Berndsen, Kathrin Kübler, Norbert R. Holtmann, Henrik Rothamel, Daniel Head Face Med Research BACKGROUND: The aim of this study was to compare new bone formation, resorbed bone matrix, and fibrous enclosed residual bone substitute material in laterally augmented alveolar bone defects using allogeneic, pre-treated and cleaned human bone blocks (tested in dogs, therefore considered to be xenogeneic), and pre-treated and cleaned bovine cancellous bone blocks, both with and without a collagen membrane in order to evaluate their augmentative potential. METHODS: Thirty-two critical size horizontal defects were prepared in the mandible of 4 adult foxhound dogs (8 per dog, 4 on each side). After 3 months of healing, the defects were laterally augmented in a split-mouth-design with either human (HXB) or bovine solvent-preserved bone blocks (BXB). Afterwards, defects were randomly covered with a bovine collagenous membrane (HXB + M, BXB + M). After a healing interval of 6 months, percentages of new bone formation, resorbed bone matrix, and fibrous enclosed residual bone substitute material were compared. RESULTS: Results showed little new bone formation of up to 3.7 % in human bone blocks (HXB 3.7 % ± 10.2, HXB + M 0.3 %± 0.4, BXB, 0.1 % ± 0.8, BXB + M 2.6 % ± 3.2, p = > 0.05). Percentages of fibrous encapsulation were higher in human bone blocks than in bovine bone blocks (HXB 71.2 % ± 8.6, HXB + M 73.71 % ± 10.6, BXB, 60.5 % ± 27.4, BXB + M 52.5 % ± 28.4, p = > 0.05). Resorption rates differed from 44.8 % in bovine bone blocks covered with a membrane to 17.4 % in human bone blocks (HXB 17.4 % ± 7.4, HXB + M 25.9 % ± 10.7, BXB, 38.4 % ± 27.2, BXB + M 44.8 % ± 29.6, p = > 0.05). The use of additional membranes did not significantly affect results. CONCLUSIONS: Within its limitations, results of this study suggest that solvent-preserved xenogenic human and bovine bone blocks are not suitable for lateral bone augmentation in dogs. Furthermore, defect coverage with a membrane does not positively affect the outcome. BioMed Central 2021-06-29 /pmc/articles/PMC8240406/ /pubmed/34187496 http://dx.doi.org/10.1186/s13005-021-00275-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Schorn, Lara Fienitz, Tim Berndsen, Kathrin Kübler, Norbert R. Holtmann, Henrik Rothamel, Daniel The use of solvent-preserved human and bovine cancellous bone blocks for lateral defect augmentation - an experimental controlled study in vivo |
title | The use of solvent-preserved human and bovine cancellous bone blocks for lateral defect augmentation - an experimental controlled study in vivo |
title_full | The use of solvent-preserved human and bovine cancellous bone blocks for lateral defect augmentation - an experimental controlled study in vivo |
title_fullStr | The use of solvent-preserved human and bovine cancellous bone blocks for lateral defect augmentation - an experimental controlled study in vivo |
title_full_unstemmed | The use of solvent-preserved human and bovine cancellous bone blocks for lateral defect augmentation - an experimental controlled study in vivo |
title_short | The use of solvent-preserved human and bovine cancellous bone blocks for lateral defect augmentation - an experimental controlled study in vivo |
title_sort | use of solvent-preserved human and bovine cancellous bone blocks for lateral defect augmentation - an experimental controlled study in vivo |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240406/ https://www.ncbi.nlm.nih.gov/pubmed/34187496 http://dx.doi.org/10.1186/s13005-021-00275-1 |
work_keys_str_mv | AT schornlara theuseofsolventpreservedhumanandbovinecancellousboneblocksforlateraldefectaugmentationanexperimentalcontrolledstudyinvivo AT fienitztim theuseofsolventpreservedhumanandbovinecancellousboneblocksforlateraldefectaugmentationanexperimentalcontrolledstudyinvivo AT berndsenkathrin theuseofsolventpreservedhumanandbovinecancellousboneblocksforlateraldefectaugmentationanexperimentalcontrolledstudyinvivo AT kublernorbertr theuseofsolventpreservedhumanandbovinecancellousboneblocksforlateraldefectaugmentationanexperimentalcontrolledstudyinvivo AT holtmannhenrik theuseofsolventpreservedhumanandbovinecancellousboneblocksforlateraldefectaugmentationanexperimentalcontrolledstudyinvivo AT rothameldaniel theuseofsolventpreservedhumanandbovinecancellousboneblocksforlateraldefectaugmentationanexperimentalcontrolledstudyinvivo AT schornlara useofsolventpreservedhumanandbovinecancellousboneblocksforlateraldefectaugmentationanexperimentalcontrolledstudyinvivo AT fienitztim useofsolventpreservedhumanandbovinecancellousboneblocksforlateraldefectaugmentationanexperimentalcontrolledstudyinvivo AT berndsenkathrin useofsolventpreservedhumanandbovinecancellousboneblocksforlateraldefectaugmentationanexperimentalcontrolledstudyinvivo AT kublernorbertr useofsolventpreservedhumanandbovinecancellousboneblocksforlateraldefectaugmentationanexperimentalcontrolledstudyinvivo AT holtmannhenrik useofsolventpreservedhumanandbovinecancellousboneblocksforlateraldefectaugmentationanexperimentalcontrolledstudyinvivo AT rothameldaniel useofsolventpreservedhumanandbovinecancellousboneblocksforlateraldefectaugmentationanexperimentalcontrolledstudyinvivo |